Toggle navigation
Home
Search
Services
Blog
Contact
About
Dietary Mutagens and Breast Cancer
Gaubatz, James W.
University of South Alabama, Mobile, AL, United States
Search 6 grants from James Gaubatz
Search grants from University of South Alabama
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Biomarkers Of Oxidative Stress Study
Inflammation and Therapy for Respiratory Virus Infection
Mortality & Morbidity in Hemodialysis Patients:
Immunological Mechanisms in Lung Defense and Disease
Organization and Expression of Chloroplast Trna Genes
Recently added grants:
Timing & Associative Learning
Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade
Genetically-encoded ACh sensors
Functional roles of genetic risk factors for brain disorders in neurogenesis and neurodevelopment
Microchip for HBV testing using HIV-infected blood samples
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA078510-03
Application #
6376849
Study Section
Nutrition Study Section (NTN)
Program Officer
Poland, Alan P
Project Start
1999-04-01
Project End
2003-03-31
Budget Start
2001-04-01
Budget End
2003-03-31
Support Year
3
Fiscal Year
2001
Total Cost
$174,201
Indirect Cost
Institution
Name
University of South Alabama
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Mobile
State
AL
Country
United States
Zip Code
36688
Related projects
NIH 2001
R01 CA
Dietary Mutagens and Breast Cancer
Gaubatz, James W. / University of South Alabama
$174,201
NIH 2000
R01 CA
Dietary Mutagens and Breast Cancer
Gaubatz, James W. / University of South Alabama
$169,127
NIH 1999
R01 CA
Dietary Mutagens and Breast Cancer
Gaubatz, James W. / University of South Alabama
Publications
Dubuisson, Jeffrey G; Dyess, Donna L; Gaubatz, James W
(2002)
Resveratrol modulates human mammary epithelial cell O-acetyltransferase, sulfotransferase, and kinase activation of the heterocyclic amine carcinogen N-hydroxy-PhIP.
Cancer Lett 182:27-32
Comments
Be the first to comment on James Gaubatz's grant